Teijin Ltd. (TYO:3401) is taking measures to expand its product lineup for bone and joint diseases, a strategic area in…...
Please subscribe to read the full story.
Teijin Pharma
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
With the novel coronavirus spreading throughout the world, there are calls for a treatment to be made practical as soon…...
Please subscribe to read the full story.
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Japan is starting up development for a number of vaccines and treatments to deal with the novel coronavirus. One effort…...
Please subscribe to read the full story.
